Skip to main content

Blue Jet Healthcare Ltd

NSE: BLUEJET BSE: 544009Pharma

Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.[1]

416
52W: ₹325 — ₹1028
PE 24.6 · Book ₹72.4 · +475% vs book
Market Cap₹7,215 Cr
Stock P/E24.6Price to Earnings
ROCE39.8%Return on Capital
ROE30.2%Return on Equity
Div. Yield0.28%Face Value ₹2

Strengths

  • +Company is almost debt free.
  • +Company is expected to give good quarter
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 26.8%

Shareholding Pattern

Promoters79.81%
FIIs0.89%
DIIs4.51%
Public14.8%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters86%86%86%86%86%79.81%6.279.81%79.81%
FIIs2.02%2.18%0.21.1%1.12.28%1.21.97%0.31.83%0.11.14%0.70.89%0.2
DIIs2.14%1.75%0.42.02%0.31.33%0.70.95%0.43.63%2.74.65%1.04.51%0.1
Public9.83%10.06%0.210.87%0.810.38%0.511.08%0.714.74%3.714.41%0.314.8%0.4

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales181167184163208318340355165192
Expenses119112131119139194200234111146
Operating Profit63555344691241401215547
OPM %35%33%29%27%33%39%41%34%33%24%
Net Profit483240385899110915240
EPS ₹2.761.852.292.183.365.716.355.263.012.32

AI Insights

Revenue Trend

TTM revenue at ₹1,053Cr, up 2.2% YoY. OPM at 34%.

Debt Position

Borrowings at ₹21Cr. Debt-to-equity ratio: 0.02x. Healthy balance sheet.

Capex Cycle

CWIP at ₹159Cr (52% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 4.51% (+0.81pp change). FIIs: 0.89% (-2.04pp change). Promoters hold 79.81%.

Margin & Efficiency

ROCE improving from 0% (Mar 2020) to 40% (Mar 2025). Working capital days: 157.

Valuation

PE 24.6x with 39.8% ROCE. Price is 475% above book value of ₹72.4. Dividend yield: 0.28%.

Recent Announcements